Search

Attention all phage researchers! You’re invited to participate in an exciting initiative to help establish draft phage bank management guidelines for the community. Please register your interest in participating here. The process will unf

This week Phagecast published a new episode featuring an interview with Martin Loessner! You can hear very valuable insights in what is important to have a successful scientific career together with some phage science: how L-forms become re

The Evergreen International Phage Meeting is happening Aug 6-11, 2023, live in Olympia, Washington, USA! This is an in-person meeting, better known as Phage Camp! Come present your phage work, climb mountains with other phage scientists, pl

The Evergreen Phage Meeting organizing committee invite you to take part in a photo contest and get a chance to win awesome phage swag! Send us your favorite photo featuring or taken with Betty Kutter, and let's shower her with love at the

The UK phage biotech company, Fixed Phage, has appointed Dr Neil Clelland as its new CEO, along with a new COO and Executive Chairman. The company is looking to build on its position in the phage industry and provide innovative solutions fo

Sabrina Green and colleagues published a retrospective observational study of 12 cases of expanded access customized phage therapy. They found that customized phage production and therapy was safe and yielded favorable clinical or microbiol

Due to technical limitations, most gut microbiome studies have focused on prokaryotes, overlooking viruses. Yishay Pinto and colleagues have published a new paper on Phanta: a new method for quickly and simply identifying and quantifying ph

Agnès Oromí-Bosch and colleagues published a new report on phage resistance-related challenges associated with phage therapy. They review two main strategies for mitigating resistance in phage therapy: 1) smartly identify/design the phages

Emma George and colleagues have discovered a highly complex community of endosymbionts and a phage within a single cryptomonad cell, which is a model for organelle evolution. The Cryptomonas cell is an endosymbiotic conglomeration with seve

Attention all phage researchers! You’re invited to participate in an exciting initiative to help establish draft phage bank management guidelines for the community. To get started, please register your interest by completing this pre-quest

The Evergreen International Phage Meeting is happening Aug 6-11, 2023, live in Olympia, Washington, USA! This is an in-person meeting, better known as Phage Camp! Come present your phage work, climb mountains with other phage scientists, pl

A new phage therapy company has launched! Phiogen is a spinoff from Baylor College of Medicine, located at Texas Medical Center's Innovation Hub. Based on TAILOR Labs’ phage therapy work, and building on patented technology for evolving pha

Fixed Phage has shown that their technology, which stably immobilizes phages to excipients, can efficiently treat acne when immobilized onto nylon beads and delivered through a cream, reducing the bacterial load on the skin.

In a new preprint, Ritam Das and colleagues have systematically characterized the genomic characteristics, lifestyle, and potential therapeutic applications of ten B1 sub-cluster mycobacteriophages. They predicted the function of 55% of the

In the arms race between bacteria and phages, some large-genome jumbo phages have evolved a protein shell that encloses their replicating genome. In a new preprint, Eray Enustun and colleagues have used proximity labeling to identify a ‘pha

Tanita Wein and colleagues have published a new preprint on caspase recruitment domains (CARDs), which play a crucial role in inflammasome activity and pyroptosis. They found that CARD-like domains are present in phage defense systems, and

Nature Communications paper that builds artificial viral vectors (AVVs) from bacteriophage T4 components: a 120 × 86 nm capsid shell that holds 171-Kbp DNA and thousands of protein copies is loaded with DNAs, proteins, RNAs and ribonucleopr

Phage utility against Burkholderia cepacia complex species has been restricted by the prevailing paradigm of only using rare, obligately lytic phages, due to the perception that lysogenic phages are therapeutically unsuitable. Philip Lauman

Aleksandra Petrovic Fabijan and colleagues have written a perspective piece on translating phage therapy into the clinic. They delve into the history, turning points, recent studies and successes, and dig into the remaining biological, regu

Temperate phages drive bacterial genome evolution and impact human health. In a new paper, Justin Silpe and colleagues explore interprophage competition during polylysogeny, shedding light on induction mechanisms and strategies.